1. Home
  2. IRON vs SHOO Comparison

IRON vs SHOO Comparison

Compare IRON & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$70.47

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$38.42

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
SHOO
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
IRON
SHOO
Price
$70.47
$38.42
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$103.18
$42.43
AVG Volume (30 Days)
356.5K
955.9K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.23%
EPS Growth
N/A
N/A
EPS
N/A
0.63
Revenue
N/A
$2,534,109,000.00
Revenue This Year
N/A
$12.39
Revenue Next Year
$283.52
$5.90
P/E Ratio
N/A
$59.72
Revenue Growth
N/A
11.00
52 Week Low
$39.20
$19.06
52 Week High
$99.50
$46.88

Technical Indicators

Market Signals
Indicator
IRON
SHOO
Relative Strength Index (RSI) 64.19 64.77
Support Level $57.79 $31.85
Resistance Level $82.70 $40.18
Average True Range (ATR) 2.83 1.17
MACD 1.07 0.73
Stochastic Oscillator 96.17 99.09

Price Performance

Historical Comparison
IRON
SHOO

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

Share on Social Networks: